Sunshine Guojian Pharmaceutical (688336.SH) has announced a forecasted net profit of 700 million to 772 million yuan, an increase of 137.73% to 162% compared to the previous year.

Sunshine Guojian Pharmaceutical (688336.SH) released its annual performance forecast for 2024, with an estimated net profit attributable to the company's owners of 7 billion to 7.72 billion yuan, an increase of 137.73% to 162.00% year-on-year; it is expected to achieve a net profit attributable to the company's owners after deducting non-recurring gains and losses of 2.39 billion to 2.79 billion yuan, an increase of 15.57% to 34.83% year-on-year.